Down 50%, Is Chewy Stock a Buy on the Latest Dip?

Chewy reported quarterly revenue growth of more than 7% to $3.33 billion, adjusted EPS of $0.36 (+9% YoY), and adjusted EBITDA of $226.7 million (+7% YoY), though results included roughly $15 million of non-recurring benefits and shares fell 11% after earnings. EBITDA margin expanded 90bps to 6.8%, while Autoship sales rose more than 9% to $2.82 billion and represented nearly 85% of revenue. Management raised full-year revenue guidance to $13.46 billion-$13.57 billion and EBITDA-margin guidance to 6.7%-6.8%, but cited stressed consumers and expects continued pet-industry pressure through year-end.

Analysis

The selloff creates a distinction between reported earnings and underlying earnings quality: one-time commercial/accounting benefits appear to have pulled profit into the quarter, so the next report must demonstrate that fulfillment productivity, advertising mix, and service automation can offset that normalization. The key debate is not demand durability but whether incremental revenue converts to EBITDA at a rate sufficient to justify multiple expansion; a sub-7% EBITDA-margin business remains vulnerable to even modest freight, wage, or promotional pressure.

Near term, CHWY is likely range-bound until management proves that recurring-customer economics can sustain organic growth despite discretionary category weakness. Over 1-3 months, evidence of stable customer retention and a clean margin bridge should be a catalyst because the market is pricing the company more like a low-growth general retailer than a recurring-revenue consumables platform. Over 6-18 months, healthcare and advertising are strategically more important than consumer AI: both raise gross-profit dollars per customer and reduce direct comparability with Amazon/Walmart price competition.

The contrarian risk is that perceived recession resilience is already reflected in the recurring-delivery mix, while customer spend deceleration signals share-of-wallet pressure that can migrate from treats into core categories if value-oriented competitors intensify promotions. A forward earnings multiple near low-teens is inexpensive only if earnings estimates do not reset after temporary benefits roll off. Thesis is falsified by organic growth below roughly 5%, recurring-customer sales decelerating materially, or EBITDA margin failing to hold the guided range after normalization.

Key Decisions for Investors

• Initiate a half-size long CHWY only after post-earnings volatility stabilizes; target a 3-6 month rerating on clean underlying margin delivery rather than the reported quarter. Underwrite approximately 15-25% upside from multiple normalization, with a 10-12% stop if the next update shows organic growth below 5% or a margin-guide cut.
• For market-neutral exposure, pair long CHWY against XRT over the next 1-3 months. The hedge isolates recurring pet-consumables and healthcare/advertising mix from a broader discretionary-retail slowdown; close the pair if CHWY customer-spend metrics weaken faster than broad retail sales.
• Do not add aggressively ahead of the next earnings release. Require a reconciliation of temporary benefits, sequential gross-margin seasonality, and fulfillment-cost savings; absent that disclosure, treat the apparent valuation discount as an earnings-quality discount rather than a catalyst.
• Monitor AMZN and WMT pet-category pricing and delivery-membership promotions as a structural watch item. A sustained promotional response would impair CHWY's ability to convert membership and healthcare initiatives into margin expansion, even if top-line retention remains intact.